Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Liver Cancer After Liver Transplantation”

33 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 33 results

Not applicableStudy completedNCT06307158
What this trial is testing

Influence of Intraoperative Blood Salvage and Autotransfusion on Tumor Recurrence After Deceased Donor Liver Transplantation

Who this might be right for
Liver Transplant; Complications
Zhejiang University 998
Not applicableStudy completedNCT05200195
What this trial is testing

Deep Learning Model for the Prediction of Post-LT HCC Recurrence

Who this might be right for
Liver Transplant DisorderLiver CancerRecurrent Cancer
European Hepatocellular Cancer Liver Transplant Group 4,026
Early research (Phase 1)Study completedNCT02686372
What this trial is testing

TCR-Redirected T Cell Infusion to Prevent Hepatocellular Carcinoma Recurrence Post Liver Transplantation

Who this might be right for
Hepatocellular Carcinoma
Lion TCR Pte. Ltd. 13
Testing effectiveness (Phase 2)UnknownNCT05833126
What this trial is testing

Hepatic Arterial Infusion Chemotherapy in Combination With Atezolizumab and Bevacizumab for Second-line Treatment of Patients With Recurrent Liver Cancer After Liver Transplantation

Who this might be right for
Recurrent Liver Cancer After Liver Transplantation
Shuhong Yi 25
Not applicableStudy completedNCT06233708
What this trial is testing

Association Between Pre-op Non-Selective Beta-Blockers and Hepatocellular Carcinoma Recurrence Post-Liver Transplant

Who this might be right for
Hepatocellular Carcinoma RecurrentHepatocellular Carcinoma
Asan Medical Center 2,092
Not applicableStudy completedNCT06720675
What this trial is testing

Ex-vivo Hypotermic Perfusion in Patients with Hepatocellular Carcinoma to Reduce the Incidence of Tumor Recurrence

Who this might be right for
Liver CarcinomaLiver TransplantTumor Recurrence+2 more
IRCCS Azienda Ospedaliero-Universitaria di Bologna 237
Not applicableStudy completedNCT06799468
What this trial is testing

Validation of the TRAIN-AI for the Risk of HCC Recurrence After Liver Transplantation

Who this might be right for
Hepatocellular Carcinoma (HCC)Liver TransplantationDeep Learning Model
European Hepatocellular Cancer Liver Transplant Group 1,769
Not applicableUnknownNCT01125020
What this trial is testing

Impact of Postoperative Adjuvant Chemotherapy in Patients With Hepatocellular Carcinoma After Liver Transplantation

Who this might be right for
Liver TransplantationHepatocellular CarcinomaTumor Recurrence and Metastasis+2 more
Shanghai Jiao Tong University School of Medicine 150
Early research (Phase 1)Study completedNCT00844168
What this trial is testing

Sorafenib Tosylate in Treating Patients With Liver Cancer Who Have Undergone a Liver Transplant

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Resectable Adult Primary Liver Cancer+2 more
University of Washington 4
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06409637
What this trial is testing

FOLFOX Plus Lenvatinib Adjuvant Therapy for Hepatocellular Carcinoma Post-Liver Transplantation

Who this might be right for
Liver CancerLiver Transplant
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 62
Early research (Phase 1)UnknownNCT04677088
What this trial is testing

TCR-Redirected T Cell Treatment in Patients With Recurrent HBV-related Hepatocellular Carcinoma Post Liver Transplantation

Who this might be right for
Recurrent Hepatocellular Carcinoma
Xiaoshun He 7
Not applicableUnknownNCT05876052
What this trial is testing

HOPE to Reduce Tumour Recurrence After LT In Patients With HCC

Who this might be right for
Liver CancerTumor RecurrenceHepatocellular Carcinoma+2 more
University of Bologna 192
Not applicableUnknownNCT03839706
What this trial is testing

Relationship Between 18FDG PET/MRI Patterns and ctDNA to Predict HCC Recurrence After Liver Transplantation

Who this might be right for
Hepatocellular Carcinoma
University Health Network, Toronto 20
Testing effectiveness (Phase 2)Study completedNCT01559844
What this trial is testing

Efficacy of Sofosbuvir With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant

Who this might be right for
Hepatitis CHepatocellular Carcinoma
Gilead Sciences 61
Not applicableStudy completedNCT03775863
What this trial is testing

AFP Model and Liver Transplantation.

Who this might be right for
Liver CarcinomaLiver Transplant Disorder
Austral University, Argentina 1,200
Testing effectiveness (Phase 2)Study completedNCT01624285
What this trial is testing

Sorafenib Tosylate Following a Liver Transplant in Treating Patients With Liver Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaLocalized Resectable Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more
Jonsson Comprehensive Cancer Center 20
Testing effectiveness (Phase 2)WithdrawnNCT03634683
What this trial is testing

LioCyx in Patient With Recurrent HBV-related HCC Post Liver Transplantation

Who this might be right for
Recurrent Hepatocellular Carcinoma
Lion TCR Pte. Ltd.
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06041490
What this trial is testing

Adjuvant Therapy for High-risk Hepatocellular Carcinoma Post Liver Transplantation

Who this might be right for
Liver Transplant; ComplicationsHepatocarcinomaRecurrent Osteosarcoma+1 more
Peking Union Medical College Hospital 88
Early research (Phase 1)UnknownNCT02719782
What this trial is testing

TCR-Redirected T Cell Infusion in Subject With Recurrent HBV-related HCC Post Liver Transplantation

Who this might be right for
Recurrent Hepatocellular Carcinoma
Lion TCR Pte. Ltd. 10
Load More Results